---
title: "TCL1 Breakapart Probe, Fluorescence in situ hybridisation (FISH) is a techniq... — FDA record Z-0814-2022 | Is It on Recall"
description: "May show unexpected locus specific signals in addition to those at 14q32."
url: https://isitonrecall.com/recall/fda-device-z-0814-2022-tcl1-breakapart-probe-fluorescence-in-situ-hybridisation-fish-is-a-technique-allows-the-visualisatio/
updated: 2026-10-01
site: "Is It on Recall"
language: en
---

[Recall archive](https://isitonrecall.com/archives/) / FDA device enforcement

# TCL1 Breakapart Probe, Fluorescence in situ hybridisation (FISH) is a technique allows the visualisation of DNA seque... — FDA record Z-0814-2022

Reported terminated

Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.

Source date Feb 4, 2022. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; [check FSIS directly](https://www.fsis.usda.gov/recalls). [Source coverage and dates](https://isitonrecall.com/sources/).

## What the record says

- **Product**: TCL1 Breakapart Probe, Fluorescence in situ hybridisation (FISH) is a technique allows the visualisation of DNA sequences upon chromosome Catalog Number: LPH046-A
- **Reason**: May show unexpected locus specific signals in addition to those at 14q32.
- **Classification**: Class III
- **Recalling firm**: Cytocell Ltd.
- **Quantity**: 1 unit
- **Agency-reported status**: Terminated
- **Source record identifier**: Z-0814-2022

[Open the official record](https://api.fda.gov/device/enforcement.json?search=recall_number%3A%22Z-0814-2022%22)

[What the recall classes mean](https://isitonrecall.com/guides/recall-classes/). Classification is an agency assessment, not individual medical advice.

## Lot and product identifiers

| Label field | Details supplied by the agency |
| --- | --- |
| Lot, code or applicability | Lot 074612 |

Match all identifying details in the current notice. A brand name alone is not enough.

## Distribution

MN

States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.

- [Minnesota](https://isitonrecall.com/state/minnesota/)

## Dates in the source

- **Report date**: Mar 30, 2022
- **Recall initiation date**: Feb 4, 2022
- **Center classification date**: Mar 21, 2022
- **Termination date**: Nov 6, 2024

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.

## What to do next

Read the official notice for the action that applies to your exact product.

[Read the current instructions](https://api.fda.gov/device/enforcement.json?search=recall_number%3A%22Z-0814-2022%22)

## Related records

[Medical devices records](https://isitonrecall.com/category/medical-devices/) [Cytocell Ltd. records](https://isitonrecall.com/brand/cytocell-ltd/)